Showing 1 - 2 results of 2 for search 'Federica Bertolini', query time: 0.01s Refine Results
  1. 1
    Carboplatin, etoposide, atezolizumab, and bevacizumab in the first-line treatment of patients with extensive stage small-cell lung cancer: the GOIRC-01-2019 CeLEBrATE study

    Carboplatin, etoposide, atezolizumab, and bevacizumab in the first-line treatment of patients with extensive stage small-cell lung cancer: the GOIRC-01-2019 CeLEBrATE study by Marcello Tiseo, Corrado Ficorella, Andrea Ardizzoni, Carlo Genova, Francesca Mazzoni, Giuseppe Lamberti, Luca Boni, Ida Colantonio, Alessandro Leonetti, Saverio Cinieri, Andrea Bonetti, Michele Tognetto, Federica Bertolini, Alessandro Follador, Elisa Andrini, Antonio Frassoldati, Francesco Gelsomino, Giulia Pasello, Karim Rihawi, Ferdinando Riccardi, Donatella Giardina, Matteo Brighenti

    Published 2025-05-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Metabolically activated and highly polyfunctional intratumoral VISTA+ regulatory B cells are associated with tumor recurrence in early-stage NSCLC

    Metabolically activated and highly polyfunctional intratumoral VISTA+ regulatory B cells are associated with tumor recurrence in early-stage NSCLC by Domenico Lo Tartaro, Beatrice Aramini, Valentina Masciale, Nikolaos Paschalidis, Francesco Demetrio Lofaro, Anita Neroni, Rebecca Borella, Elena Santacroce, Alin Liviu Ciobanu, Anna Valeria Samarelli, Federica Boraldi, Daniela Quaglino, Alessandra Dubini, Michele Gaudio, Gloria Manzotti, Francesca Reggiani, Federica Torricelli, Alessia Ciarrocchi, Antonino Neri, Federica Bertolini, Massimo Dominici, Pier Luigi Filosso, Franco Stella, Lara Gibellini, Sara De Biasi, Andrea Cossarizza

    Published 2025-01-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: